Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to 0.05%.

  • Kiniksa Pharmaceuticals International's Return on Invested Capital rose 1100.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.12% for FY2024, which is 800.0% down from last year.
  • Kiniksa Pharmaceuticals International's Return on Invested Capital amounted to 0.05% in Q3 2025, which was up 1100.0% from 0.0% recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Return on Invested Capital ranged from a high of 0.41% in Q3 2022 and a low of 0.79% during Q4 2021
  • Moreover, its 5-year median value for Return on Invested Capital was 0.05% (2024), whereas its average is 0.11%.
  • Within the past 5 years, the most significant YoY rise in Kiniksa Pharmaceuticals International's Return on Invested Capital was 9400bps (2023), while the steepest drop was -4600bps (2023).
  • Kiniksa Pharmaceuticals International's Return on Invested Capital (Quarter) stood at 0.79% in 2021, then soared by 109bps to 0.07% in 2022, then crashed by -156bps to 0.04% in 2023, then tumbled by -215bps to 0.12% in 2024, then skyrocketed by 144bps to 0.05% in 2025.
  • Its Return on Invested Capital stands at 0.05% for Q3 2025, versus 0.0% for Q2 2025 and 0.09% for Q1 2025.